Why is Bafna Pharma. falling/rising?

As of 14-Nov, Bafna Pharmaceuticals Ltd is experiencing a decline in its stock price, currently at Rs 181.45, which reflects a decrease of Rs 3.7 or 2.0%. The stock has been underperforming recently, having lost 7.54% over the last three days and is currently trading at a low of Rs 181.45. Additionally, the stock has shown a negative performance today, underperforming its sector by 2.37%. Despite a strong year-to-date return of 137.19% and a significant increase of 258.60% over the past five years, the recent trend indicates a downturn, compounded by a drastic drop in delivery volume, which fell by 93.18% compared to the five-day average.
In the broader market context, Bafna Pharmaceuticals' recent performance contrasts sharply with the Sensex, which has gained 1.62% over the past week. While the stock has shown impressive long-term growth, its recent short-term performance has not kept pace with the benchmark, highlighting a potential disconnect between the stock's historical performance and current investor sentiment. The stock's liquidity remains adequate for trading, but the falling investor participation suggests a lack of confidence that could be contributing to the recent price decline.